As of 2025-07-15, the Gross Margin of Rohto Pharmaceutical Co Ltd (4527.T) is 56.7%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2025-03-31 | 56.7% |
2024-03-31 | 58.1% |
2023-03-31 | 57.6% |
2022-03-31 | 58.2% |
2021-03-31 | 59% |
2020-03-31 | 60.6% |
2019-03-31 | 59.7% |
2018-03-31 | 58.8% |
2017-03-31 | 59.1% |
2016-03-31 | 59.7% |